Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway
Vasculogenic mimicry (VM) differs from the classical tumor angiogenesis model. VM does not depend on endothelial cells; instead, highly aggressive tumor cells mimic endothelial cells to form a vascular-like channel structure. VM mediated by tumor cells is significantly and positively associated with...
Main Authors: | Ju Huang, Congcong Wang, Yixuan Hou, Yuanyuan Tian, Yanru Li, Haiying Zhang, Lihong Zhang, Wei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223012532 |
Similar Items
-
CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix
by: Carmela Martini, et al.
Published: (2021-07-01) -
Vasculogenic mimicry persists during glioblastoma xenograft growth
by: Cong Li, et al.
Published: (2018-01-01) -
Therapeutic potential of vasculogenic mimicry in urological tumors
by: Xinyu Lin, et al.
Published: (2023-09-01) -
Vasculogenic mimicry in carcinogenesis and clinical applications
by: Qingxi Luo, et al.
Published: (2020-03-01) -
Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
by: César López-Camarillo, et al.
Published: (2020-07-01)